LPL Financial
NYMX

LPL Financial’s Nymox Pharmaceutical Corp NYMX Stock Holding History

LPL Financial’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,500
Closed -$25K – 3371
2019
Q1 		$25K Sell
12,500
-3,000
-19% -$6.36K ﹤0.01% 3149
2018
Q4 		$20K Buy
15,500
+3,000
+24% +$5.49K ﹤0.01% 3038
2018
Q3 		$31K Hold
12,500
– – ﹤0.01% 3189
2018
Q2 		$42K Hold
12,500
– – ﹤0.01% 3155
2018
Q1 		$53K Buy
12,500
+500
+4% +$1.73K ﹤0.01% 3116
2017
Q4 		$40K Buy
+12,000
New +$43.8K ﹤0.01% 2981

Other funds holding NYMX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

LPL Financial's NYMX Position: Q2 2019 in Review

LPL Financial sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2019, closing a stake of 12,500 shares — an estimated $25K sold.

LPL Financial first reported a position in NYMX in Q4 2017 and held it in 6 quarters. The position peaked at $53K in Q1 2018. 41 funds tracked by Wall St. Rank hold NYMX as of Q2 2019.

  • LPL Financial reported no remaining Nymox Pharmaceutical Corp position as of Q2 2019 after selling out during the quarter.
  • LPL Financial sold 12,500 Nymox Pharmaceutical Corp shares in Q2 2019, an estimated $25K.
  • LPL Financial first reported a position in Nymox Pharmaceutical Corp in Q4 2017 and held it in 6 quarters.
  • LPL Financial's Nymox Pharmaceutical Corp position peaked at $53K in Q1 2018.
  • 41 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2019.

Based on LPL Financial's 13F filing for Q2 2019, filed 9 Aug 2019.